Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lexaria Bioscience Corp. Director's Dealing 2015

Aug 24, 2015

34983_dirs_2015-08-24_9cb40ad4-1e5a-4f5a-9c4b-d96ccdabd67b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2015-03-26

Reporting Person: DOCHERTY JOHN MARTIN (President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-08-17 Common Shares D 500000 $0.17 Disposed 130000 Indirect
2015-08-17 Common Shares P 420000 $0.2 Acquired 550000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 630000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options $0.1 2020-03-26 Common Shares (500000) 500000 Direct
Warrants $0.25 2017-05-15 Common Shares (130000) 130000 Indirect

Footnotes

F1: These shares were cancelled and returned to treasury as the amount was issued in error.

F2: These shares were issued following the cancellation and return to treasury of 500,000 shares which were issued in error.